KORU Medical Systems

Update in progress

KRMD (NasdaqCM)

Company RatingNeutral
SectorHealthcare
IndustryMedical Instruments & Supplies

KORU Medical Systems develops, manufactures, and markets subcutaneous infusion solutions for the U.S. and international markets. It offers the FREEDOM infusion systems for delivering therapies to patients with chronic conditions such as PIDD, CIDP, SIDD, and PNH. Products include the FREEDOM60 syringe driver, FreedomEdge syringe driver, High-Flo subcutaneous safety needle sets, and precision flow tubing. Formerly Repro Med, renamed in 2022. Based in Mahwah, New Jersey, and founded in 1980.

Company score

Sentiment: 0.30; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.00; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.00; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.00; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.15; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive